[Form 4] Corning Incorporated Insider Trading Activity
Rhea-AI Filing Summary
Seetharam Soumya, Senior Vice President & CDIO of Corning Incorporated (GLW), reported insider transactions dated 08/08/2025. The filing shows an acquisition (Code M) of 2,260 common shares at $0 and a sale (Code F) of 875 common shares at $65.77. Following these transactions the report lists 27,260 shares beneficially owned after the acquisition and 26,385 after the sale, as shown in the form.
The report also details multiple restricted stock unit (RSU) positions convertible into common stock: 14,692, 12,187, and 13,734 RSUs, plus 2,260 RSUs referenced with the 08/08/2025 transaction. The filing states each RSU represents a contingent right to one share and lists vesting dates of 04/15/2026, 04/15/2027, and 04/14/2028, with an additional vesting schedule for RSUs granted 02/08/2023. The form is signed by Power of Attorney Melissa J. Gambol on 08/12/2025.
Positive
- Clear RSU disclosure with specific vesting dates (04/15/2026, 04/15/2027, 04/14/2028) and quantities (14,692, 12,187, 13,734, 2,260)
- Acquisition (Code M) of 2,260 shares reported on 08/08/2025, increasing reported beneficial ownership to 27,260 shares
Negative
- Sale (Code F) of 875 shares executed at $65.77 on 08/08/2025, reducing reported holdings to 26,385 on that line
- Transactions centered on officer compensation and dispositions may be interpreted as insider liquidity events by some stakeholders
Insights
TL;DR: Insider reported both a small sale and an RSU settlement, leaving ~27k shares beneficially owned.
The filing shows a contemporaneous sale of 875 shares at $65.77 and an acquisition/settlement of 2,260 shares (Code M) on 08/08/2025, producing reported beneficial ownership figures of 27,260 and 26,385 depending on the line item. The form discloses sizeable outstanding RSU awards convertible into common stock and explicit vesting dates through 2028, which are compensation-related instruments rather than open-market purchases. For investors, these are routine officer compensation and liquidity transactions documented under Section 16.
TL;DR: Transaction mix reflects compensation vesting and an executed sale; disclosure is complete with vesting schedules and POA signature.
The Form 4 provides clear disclosure: RSUs described as contingent rights to shares, explicit vesting timelines (04/15/2026; 04/15/2027; 04/14/2028) and a staged vesting schedule for the 02/08/2023 grant. The filing includes a Power of Attorney signature dated 08/12/2025, satisfying procedural requirements. From a governance perspective, documentation appears thorough and compliant with Section 16 reporting norms.